As proof of concept, this was then tested in vivo: TNFα blocking antibody administered during peritonitis in CGD animals promoted maturation of recruited MoMacs and adoptively transferred MoMacs lacking TNFR1 went on to phenotypically mature in the inflamed CGD peritoneum. Here, TNF is linked to chronic granulomatous disease.